Induction of differentiation by wild-type p53 gene in a human glioma cell line

Journal of Neuro-Oncology

Volumn 32, Issue 2, 1997, Pages 125-133

  Kokunai, Takashi ^a   Kawamura, Atsufumi ^a   Tamaki, Norihiko ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Cell cycle; Differentiation; Glioma; p21; p53 gene

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN P53;

ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; GENE INDUCTION; GENE TRANSFER; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; PHENOTYPE;

BRAIN NEOPLASMS; CDC2-CDC28 KINASES; CELL DIVISION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; HUMANS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN-SERINE-THREONINE KINASES; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0031051952     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005732003296     Document Type: Article

References (43)

1. Donehower LA, Bradley A: The tumor suppressor p53. Biochim Biophys Acta 1155: 181-205, 1993
2. Vogelstein B, Kinzer KW: p53 function and dysfunction. Cell 70: 523-526, 1992
3. Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Bakers SJ, Vogelstein B, Friend SH: p53 functions as cell cycle control protein in osteosarcomas. Mol Cell Biol 10: 5772-5781, 1990
4. Martinez J, Georgoff I, Martinez J, Levin AJ: Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5: 151-159, 1991
5. Lin D, Shields MT, Ullrich SJ, Appella E, Mercer WE: Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1-phase. Proc Natl Acad Sci USA 89: 9210-9214, 1992
6. Kuerbitz SJ, Plunkett B S, Walsh WV, Kastan MB: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89: 7491-7500, 1992
7. Shaulsky G, Goldfinger N, Peled A, Rotter V: Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc Natl Acad Sci USA 88: 8982-8986, 1991
8. Feinstein E, Gale RP, Reed J, Canaani E: Expression of normal p53 gene induces differentiation of K562 cells. Oncogene 7: 1853-1857, 1992
9. Radinsky R, Fidler IJ, Price JE, Esumi N, Tsan R, Petty CM, Bucana CD, Bar-Eli M: Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53. Oncogene 9: 1877-1883, 1994
10. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 cdk-interaction protein cip 1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993
11. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B: WAF 1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993
12. Li Y, Jenkins CW, Nichols MA, Xiong Y: Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9: 2261-2268, 1994
13. Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578, 1994
14. Chen J, Jackson PK, Kirschner MW, Dutta A: Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374: 386-388, 1995
15. Luo Y, Hurwitz J, Massagu J: Cell-cycle inhibition by independent CDK and PCNA binding domains in p21 Cip 1. Nature 375: 159-161, 1995
16. El-Diery WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Petenpol JA, Burrell MH, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzer KW, Vogelstein B: WAF1/Cip1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994
17. Jiang H, Lin J, Su Z, Collart FR, Huberman E, Fisher PB: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the abscence of p53. Oncogene 9: 3397-3406, 1994
18. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travail S, Deisseroth AB, Mercer WE: p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 55: 668-674, 1995
19. Lieberman DA, Hoffman B, Steinman RA: Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11: 199-210, 1995
20. Van Meir EG, Kikuchi T, Tada M, Li H, Diserens A, Wojcik BE, Huang HS, Friedmann T, de Tribolet N, Cavenee WK: Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 54: 649-652, 1994
21. Kyo E, Yokozaki H, Yanagihara K, Yasui W, Ito M, Sano T, Lee PS, Saya H, Tahara E: Reduced tumorigenicity and cell motility of a gastric carcinoma cell line by introduction of wild-type p53 gene. Int J Oncol 3: 265-271, 1993
22. Gannon JV, Greaves R, Iggo R, Lane D: Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 9: 1591-1602, 1990
23. Cook A, Milner J: Evidence for allosteric variants of wild-type p53, a tumour suppressor protein. Br J Cancer 61: 548-552, 1990
24. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970
25. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979
26. MacPherson L, Montagnier I: A gar suspension culture for the selective assay of cells transformed by polyoma virus. Virology 23: 291-294, 1964
27. Stewart N, Hicks GC, Paraskevas F, Mowat M: Evidence for a second cell cycle block at G2/M by p53. Oncogene 10: 109-115, 1995
28. Merzak A, Raynal S, Rogers JP, Lawrence D, Pilkington GJ: Human wild type p53 inhibits cell proliferation and elicits dramatic morphological changes in human glioma cell lines in vitro. J Neurol Sci 127: 125-133, 1994
29. Bongcam-Rudloff E, Nistér M, Betsholtz C, Wang J-L, Stenman G, Huebner K, Croce CM, Westermark B: Human glial fibrillary acidic protein: complementary DNA cloning, chromosome localization, and messenger RNA expression in human glioma cell lines of various phenotypes. Cancer Res 51: 1553-1560, 1991
30. Weinstein DE, Shelanski ML, Liem RHH: Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol 112: 1205-1213, 1991
31. Waldman T, Kinzler KW, Vogelstein B: p21 is necessary for p53-mediated G1 arrest in human cancer cells. Cancer Res 55: 5187-5190, 1995
32. Yang Z-y, Perkins ND, Ohno T, Nabèl EG, Nabel GJ: The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nature Med 1: 1052-1056, 1995
33. Chen P-L, Scully P, Shew J-Y, Wang JYJ, Lee W-H: Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58: 1193-1198, 1989
34. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ: p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027, 1995
35. Xlong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993
36. 3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene 10: 159-166, 1995
37. Kranenburg O S, Scharnhorst V, Van der Eb AJ, Zantema A : Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J Cell Biol 131: 227-234, 1995
38. Mercer WE, Shields MT, Lin D, Appella E, Ullrich SJ: Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc Natl Acad Sci USA 88: 1958-1962, 1991
39. Fujiwara T, Mukhopadhyay T, Cai DW, Morris DK, Roth JA, Grimm EA: Retroviral-mediated transduction of p53 gene increases TGF-β expression in a human glioblastoma cell line. Int J Cancer 56: 834-839, 1994
40. Gjerset RA, Turla ST, Sobol RE, Scalise JJ, Mercola D, Collins H, Hopkins PJ: Use of wild-type p53 to achieve complete treatment sensitization of tumor cells expressing endogeneous mutant p53. Mol Carcinogenesis 14: 275-285, 1995
41. Gomez-Manzano C, Fueyo J, Kyritsis AP, Steck PA, Roth JA, McDonnell TJ, Steck KD, Levin VA, Yung WKA: Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res 56: 694-699, 1996
42. Yonish-Rouach E, Deguin V, Zaitchouk T, Breugnot C, Mishal Z, Jenkins R, May E: Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53. Oncogene 12: 2197-2205, 1996
43. Van Meir EG, Roemer K, Diserens A-C, Kikuchi T, Rempel SA, Haas M, Huang H-JS, Friedmann T, de Tribolet N, Cavenee WK: Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells. Proc Natl Acad Sci USA 92: 1008-1012, 1995